Projects per year
Fingerprint
Dive into the research topics where Andrew Evens is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 5 Finished
-
Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform
Evens, A., HUANG, T. J., KONRY, T. T. & HUANG, T. J.
5/1/18 → 4/30/20
Project: Research project
-
MAP Kinase Signaling in Lymphoma: A Novel Therapeutic Paradigm
Evens, A., Gartenhaus, R. & Gartenhaus, R.
8/10/12 → 8/31/17
Project: Research project
-
Impact of Lifestyle with Tumor Pathways and Microenvironment on Lymphoma Survival
Evens, A., Chiu, B. C. H. & Chiu, B. C. H.
7/17/09 → 12/30/11
Project: Research project
-
-
Research Training in Oncology
Evens, A., Schwartz, R., KRONTIRIS, T., Furie, B., Levy, S., Tsichlis, P. & VAN ETTEN, R.
1/1/90 → 6/30/15
Project: Research project
Research output
-
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
Bennani, N. N., Tun, A. M., Carson, K. R., Geiger, J. L., Maeda, L. S., Savage, K. J., Rose, J., Pinter-Brown, L., Lunning, M. A., Abramson, J. S., Bartlett, N. L., Vose, J. M., Evens, A. M., Smith, S. M., Horwitz, S. M., Ansell, S. M. & Advani, R. H., May 1 2022, In: Clinical Lymphoma. 22, 5, p. e300-e309Research output: Contribution to journal › Article › peer-review
-
Characteristics and Outcome of Extranodal NK/T-Cell Lymphoma in North America: A Retrospective Multi-Institutional Experience
Bennani, N. N., Tun, A. M., Carson, K. R., Geiger, J. L., Maeda, L. S., Savage, K. J., Rose, J., Pinter-Brown, L., Lunning, M. A., Abramson, J. S., Bartlett, N. L., Vose, J. M., Evens, A. M., Smith, S. M., Horwitz, S. M., Ansell, S. M. & Advani, R. H., Apr 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, 4, p. e250-e260Research output: Contribution to journal › Article › peer-review
-
Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
Evens, A. M., Brandt, J. S., Peer, C. J., Yin, T., Schaar, D., Farooq, F., Mozarsky, B., Figg, W. D. & Sharon, E., Jun 1 2022, In: American Journal of Hematology. 97, 6, p. 833-838 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma
Dixon, J. G., Dimier, N., Nielsen, T., Zheng, J., Marcus, R., Morschhauser, F., Evens, A. M., Federico, M., Blum, K. A. & Shi, Q., 2022, (Accepted/In press) In: British Journal of Haematology.Research output: Contribution to journal › Article › peer-review
-
Older patients (aged ≥60 years) with previously untreated advanced-stage classical Hodgkin the phase lymphoma: III ECHELON-1 a detailed study analysis from the phase III ECHELON-1 study
Evens, A. M., Connors, J. M., Younes, A., Ansell, S. M., Kim, W. S., Radford, J., Feldman, T., Tuscano, J., Savage, K. J., Oki, Y., Grigg, A., Pocock, C., Dlugosz-Danecka, M., Fenton, K., Forero-Torres, A., Liu, R., Jolin, H., Gautam, A. & Gallamini, A., May 2022, In: Haematologica. 107, 5, p. 1086-1094 9 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations